CG Oncology Director Mulay James Executes High‑Profit Pair Trades While Boosting Long‑Term Stake
Mulay James’s strategic buy‑low, sell‑high trades in CG Oncology stock reveal insider confidence and long‑term upside, balancing liquidity with future value.
3 minutes to read